Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Agnosia 4Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pain, Postoperative 2Neoplasms 2Uveal Melanoma 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Rectal Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pain 1Opioid-Related Disorders 1Mucositis 1Mouth Neoplasms 1Melanoma 1Intra-abdominal Cancer 1Ileus 1Goiter 1Eye Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Chronic Pain 1Cancer Pain 1Brain Neoplasms 1

Interventions

Ipilimumab 29Nivolumab 23pembrolizumab 14incomplete Freund's adjuvant 10Cyclophosphamide 10Interleukin-2 9Melphalan 8CTLA-4 Antigen 8sargramostim 7Temozolomide 7MART-1 Antigen 7Dacarbazine 7tebentafusp 6Ranibizumab 6montanide ISA 51 5fludarabine phosphate 5fludarabine 5Sunitinib 5Radiosurgery 5Carboplatin 5Bevacizumab 5aldesleukin 4aflibercept 4Magnetic Resonance Spectroscopy 4Granulocyte-Macrophage Colony-Stimulating Factor 4Blood Specimen Collection 4Biopsy 4trametinib 3sotrastaurin 3relatlimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uveal Melanoma × Tramadol × Clear all
NCT00111046 2005-11-10

Pain Relief - Tramadol Versus Ibuprofen

Royal Liverpool University Hospital

Phase 1/2 Unknown
40 enrolled
Dermatologic

Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡